Supernus Pharmaceuticals | SUPN - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
Abbott USD 171.01B 12.96B 2026-09
ANI Pharmaceuticals USD 1.46B 206M 2026-11
Aurora Cannabis CAD 318.09M 145.93M 2026-11
Bristol-Myers Squibb USD 127.46B 9.81B 2026-09
Canopy Growth CAD 88.38M 494.19M 2026-11
Cara Therapeutics USD 30M 336M 2026-03
Corcept Therapeutics USD 7.63B 4.83B 2026-11
Eisai JPY 1.41T 5.37B 2026-11
Eli Lilly USD 1.09T 40.33B 2026-09
Novo Nordisk A/S DKK 1.4T 373.76B 2026-06
Pacira USD 1.7B 696M 2026-11
Perrigo USD 2.17B 31M 2026-11
Pfizer USD 165.12B 1.71B 2026-11
Supernus Pharmaceuticals USD 2.51B 193M 2026-09
United Therapeutics USD 28.64B 5.4B 2026-11
Xeris Pharmaceuticals USD 1.44B 70M 2026-11